MedPath

瑞阳制药股份有限公司

Ownership
-
Established
1998-03-20
Employees
-
Market Cap
-
Website
https://www.reyoung.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

455

NMPA:455

Drug Approvals

Dacomitinib Tablets

Product Name
达可替尼片
Approval Number
国药准字H20254253
Approval Date
May 27, 2025
NMPA

Dacomitinib Tablets

Product Name
达可替尼片
Approval Number
国药准字H20254252
Approval Date
May 27, 2025
NMPA

Bortezomib for Injection

Product Name
注射用硼替佐米
Approval Number
国药准字H20254063
Approval Date
May 13, 2025
NMPA

Ibuprofen Granules

Product Name
布洛芬颗粒
Approval Number
国药准字H20254044
Approval Date
Apr 30, 2025
NMPA

Avatrombopag Maleate Tablets

Product Name
马来酸阿伐曲泊帕片
Approval Number
国药准字H20253106
Approval Date
Jan 8, 2025
NMPA

Ceftazidime and Avibactam Sodium for Injection

Product Name
注射用头孢他啶阿维巴坦钠
Approval Number
国药准字H20253047
Approval Date
Jan 2, 2025
NMPA

Nicorandil for Injection

Product Name
注射用尼可地尔
Approval Number
国药准字H20249369
Approval Date
Nov 15, 2024
NMPA

Nicorandil for Injection

Product Name
注射用尼可地尔
Approval Number
国药准字H20249370
Approval Date
Nov 15, 2024
NMPA

Oxacillin Sodium for Injection

Product Name
注射用苯唑西林钠
Approval Number
国药准字H20247270
Approval Date
Nov 4, 2024
NMPA

Cefotaxime Sodium for Injection

Product Name
注射用头孢噻肟钠
Approval Number
国药准字H20247211
Approval Date
Sep 17, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 46
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.